Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

TotalEnergies reported for 9 months of 2023

10/26/23 TTE

Samolet's profit on management accounts grew by 11.2%

10/26/23 SMLT

Samolet sales increased by 27%

10/26/23 SMLT

IBM reported for 9 months of 2023

10/26/23 IBM

Segezha reported for 9 months of 2023 by RAS

10/26/23 SGZH

UAC reported for 9 months of 2023 by RAS

10/25/23 UNAC

Krasny Oktyabr reported for 9 months of 2023 by RAS

10/25/23 KROT

Seized shares of TGK-2 were transferred under the control of Gazprom Energoholding

10/25/23 TGKB

En+ Group reported for 9 months of 2023 by RAS

10/25/23 ENPG

Sovcomflot reports for 9 months of 2023 by RAS

10/25/23 FLOT